The Program

The Branch-Ready Ingredient Program

Eight stages take a qualified operating business from commercial review to recurring powder or syrup ingredient supply. Each stage ends in a documented decision before more time or money is committed.

A branch-ready ingredient program defines both the supplied powder or syrup and the way the buyer’s branches prepare, approve and reorder it. Brief & Branch screens for at least 500 kg of powder per flavor or 500 L of syrup per flavor per intended commercial production order. An operating business below that level today may be reviewed only with current operating evidence and a dated near-term path to the same scale. The screen is not a final MOQ or production commitment.

Commercial Screen

Volume is screened per flavor and per production order

Current planning screen for a commercial fit review
FormatPlanning screenHow it is applied
PowderAt least 500 kgFor each flavor or SKU in one intended commercial production order
SyrupAt least 500 LFor each flavor or SKU in one intended commercial production order

Important: powder and syrup volumes are reviewed separately, and several low-volume flavors cannot be added together to clear the screen. The final manufacturing MOQ, price and schedule are confirmed only after the formula, ingredient sourcing, packaging, documentation and production setup are reviewed.

Evidence-backed pathway: an operating business below the screen today may still request review when current usage, purchases, recurring sales, committed openings, customer demand or an approved procurement plan supports a dated near-term path to 500 kg or 500 L for the relevant flavor. No single document guarantees qualification.

Samples and pilots may use smaller evaluation quantities, but only inside a commercially qualified program. They are decision gates, not a route around the commercial screen.

Operating-Business Evidence

How an operating business supports its forecast

Our franchise beverage ingredient onboarding process is for businesses that can connect the forecast to current operations or an approved expansion inside an operating organization. An operating buyer may either meet the screen now or apply through the evidence-backed near-term pathway. Does having investment behind us change the review? Funding alone does not establish production readiness.

Existing menu or ingredient demand

Support the forecast with evidence already available to the business, such as current branch count, recent ingredient purchasing or consumption records, servings sold, and the proposed conversion from present usage to one approved ingredient.

Dated path to the commercial screen

If the operating business is below the screen today, show the current quantity, evidence supporting growth, the date it expects to reach 500 kg or 500 L for the relevant flavor, committed locations, approved budget, decision owners and the assumptions behind the forecast.

Pre-revenue, exploratory and hobby concepts without operating evidence are outside the current program. An operating business with incomplete evidence may be asked to validate usage or consolidate demand before technical work begins.

Why Decision Gates

Gates protect your budget, not our schedule

Without a documented private label production approval process Australia operators can rely on, ingredient development fails expensively when sampling, packaging and production run ahead of decisions. What does that actually look like on the ground? A branch orders stock nobody approved. A formula changes after training materials are printed.

The program prevents this by placing a gate at the end of every stage. Each gate names the input required, the output produced, the person who approves it and the condition that stops the project.

Either side may stop at a gate. A stopped project stays on record and can resume when the missing condition is met. This is how we keep unqualified spend out of your rollout.

Ingredient specification sheet reviewed beside labelled powder and syrup ingredient samples

How It Works

The eight stages in detail

Every stage lists the same five facts: what you provide, what Brief & Branch coordinates, what is produced, who approves it and what stops the project. Nothing advances on assumption.

01

Fit Assessment

Buyer input
Operating-business evidence, branch count, expected kilograms or liters per flavor and production order, forecast rhythm, packaging preference, target cost range and launch window, submitted through the fit-assessment form.
Brief & Branch coordination
Reviews whether the operating business meets the 500 kg powder or 500 L syrup per-flavor planning screen now or has a current, evidence-backed and dated near-term path to it, then tests the forecast basis and decision readiness before technical evaluation.
Output
A documented fit decision: proceed to NDA, clarify specific points, or decline with reasons.
Approval owner
Commercial review team.
Stop/go condition
A flavor below the relevant screen without a credible evidence-backed pathway, a forecast created by combining unrelated flavors, a pre-launch concept, or an unreachable decision team does not proceed.
02

Mutual NDA

Buyer input
Legal reviewer availability, signing authority and any requested amendments to the mutual NDA draft.
Brief & Branch coordination
Issues the mutual NDA and coordinates review and signature before any confidential disclosure.
Output
A signed mutual NDA covering both parties’ technical, facility and commercial information.
Approval owner
Legal reviewers for both parties.
Stop/go condition
Manufacturer identity, facility documents and formula details are not shared until the NDA is executed.
03

Product Brief

Buyer input
Formula status—existing formula, approved benchmark or new development—plus the beverage application, serving standard, target cost, packaging format and documentation requirements.
Brief & Branch coordination
Structures the brief, flags gaps and confirms what the manufacturing partner needs to evaluate feasibility.
Output
An agreed product brief that sampling, specification and costing are built against.
Approval owner
Buyer decision team.
Stop/go condition
A brief with an undefined application or a target cost the format cannot reach goes back for revision before sampling begins.
04

Sample & Specification

Buyer input
Structured evaluation of each sample round against the brief: sensory result, preparation behavior, yield and cost per serving.
Brief & Branch coordination
Coordinates sample production with the manufacturing partner and consolidates feedback into a draft ingredient specification.
Output
An approved sample tied to a draft powder or syrup specification.
Approval owner
Buyer decision team, advised by its QA reviewer.
Stop/go condition
If the target profile and target cost cannot be met in the same sample, the project pauses for a revised brief.
05

Pilot & Packaging

Buyer input
Pilot evaluation under real branch conditions, plus packaging format confirmation and label artwork for review.
Brief & Branch coordination
Coordinates the pilot run, packaging trial and label-readiness review with the manufacturing partner.
Output
A pilot report confirming the specification, packaging format and preparation method at branch scale.
Approval owner
QA reviewer, with the buyer operations lead.
Stop/go condition
A packaging or preparation failure at pilot sends the project back to specification rather than forward to production.
06

Commercial Approval

Buyer input
Confirmed forecast, final order quantities, commercial terms and written internal sign-off.
Brief & Branch coordination
Documents the project-specific MOQ, scope, assumptions, pricing basis and responsibilities on both sides for final review.
Output
A signed commercial approval authorizing recurring production against the approved specification.
Approval owner
Buyer decision team, countersigned by the commercial review team.
Stop/go condition
Production is not scheduled until the forecast, project-specific MOQ, terms and specification are approved in writing.
07

Branch Consistency Pack

Buyer input
Branch equipment list, measuring tools, training approach and the names of accountable roles per branch.
Brief & Branch coordination
Compiles the preparation standard, yield reference, storage guidance and change-control rules into one pack.
Output
A branch consistency pack the buyer uses to train, launch and audit branches on the approved ingredient.
Approval owner
Buyer operations lead, with the QA reviewer.
Stop/go condition
Rollout waits until every preparation step in the pack has an accountable owner on the buyer side.
08

Replenishment

Buyer input
Rolling forecast updates, reorder confirmations inside the agreed window and branch feedback on the ingredient in use.
Brief & Branch coordination
Coordinates production scheduling, per-delivery documentation and escalation handling with the manufacturing partner.
Output
A running replenishment plan with reorder windows, delivery documentation and a named escalation path.
Approval owner
Buyer procurement lead.
Stop/go condition
Any change to formula, packaging or process re-enters change control before the next production run.

Documentation used across the stages · The audit and due-diligence process

Before You Apply

Know How This Actually Works

Most questions buyers bring to us come down to a handful of practical concerns: timing, scale, and what happens once approval is granted.

01

Consistent Stages, Any Market

The Branch-Ready Ingredient Program follows an eight-stage process, with commercial review before sampling and piloting, and written approvals before production. Product and destination requirements are reviewed for each project.

02

Replenishment Built Around Real Usage

Once a specification is approved, a multi branch ingredient replenishment program kicks in based on actual branch consumption rather than rough estimates. Reorder timing and delivery documentation are mapped out before the first production run ships.

03

Sample and Pilot Options

Sample and pilot quantities are reviewed within the program to evaluate the formula before commercial production. Quantities remain subject to project review and approval rather than being offered as unrestricted standalone purchases.

04

Forecasts Can Shift Without Ending the Project

If numbers change midway through, the project pauses at whichever stage applies rather than falling apart entirely, and can resume once the forecast supports moving forward again.

Candid Limits

What can stop a project

Not every project reaches replenishment, and we say so before you spend on it. The most common reasons a project stops at a gate:

  • A flavor does not meet the 500 kg powder or 500 L syrup planning screen and the operating business cannot support a dated near-term path to it.
  • The forecast is not supported by current usage, purchases, recurring sales, committed openings, customer demand or an approved procurement plan.
  • The target cost and the required sensory profile cannot be met in one specification.
  • The requested packaging format is not feasible for the formula, subject to technical review.
  • Required regulatory documentation for the application is out of scope for the project.
  • Sample rounds stop converging because the brief keeps changing.
  • The buyer decision team is unavailable and approvals stall past the launch window.

A stop is a recorded outcome with a way back.

When a project stops, we record the gate, the reason and the condition that would reopen it. A project may pause at the brief or sampling stage and resume once the forecast strengthens, operating evidence is completed or the target cost is revised.

What we do not do is push a marginal project into production. An ingredient that fails at branch scale costs you far more than a paused brief.

Frequently Asked Question

What stages does a Malaysia operator go through in the Branch-Ready Ingredient Program?

A Malaysia operator moves through commercial fit review, a mutual NDA, sample and specification, pilot testing, commercial approval and ongoing replenishment. Each stage ends in a documented decision, so nothing reaches branch training or reorder until it has been formally reviewed and signed off by both sides.

How long does the qualification process typically take for a Japan brand?

Timing varies by category and how quickly samples meet the target specification, since qualification depends on sensory approval, packaging readiness and forecast confirmation rather than a fixed calendar. Japan brands with a clear product brief and confirmed volume generally move through the stages faster than undefined projects.

What does the commercial fit assessment actually evaluate for a South Korea buyer?

The commercial fit assessment reviews a South Korea buyer’s branch count, category needs, recurring volume, packaging preference and rough timeline. It also considers whether the buyer’s profile fits better as a direct chain account or an importer/distributor path, since Brief & Branch structures the program differently for each.

Can an Indonesia buyer bring an existing recipe instead of starting from a blank brief?

Yes, an Indonesia buyer can submit an existing formula, a benchmark direction, or a new product brief; all three are accepted starting points. Brief & Branch structures whichever route is chosen into a formal brief, then coordinates sampling through its manufacturing partner before moving toward pilot and commercial approval.

Who signs off before production begins for an Australia project?

Commercial approval for an Australia project requires written sign-off from both the buyer and Brief & Branch’s commercial review team, covering the confirmed forecast, pricing basis, and final specification. Production is not scheduled on the manufacturing side until this documented approval stage is fully complete.

Why does franchise onboarding take longer than a single-location ingredient order?

Franchise onboarding takes longer because a specification has to work consistently across every current and future location, not just one kitchen. Brief & Branch builds a branch consistency pack covering preparation, yield and storage guidance, so new franchise locations can be trained against one fixed, documented standard.

Does the replenishment program handle reorder timing across multiple branches automatically?

Replenishment runs on rolling forecast updates and reorder confirmations within an agreed window, rather than being fully automatic, since a multi-branch buyer’s own team still confirms quantities. Any change to formula, packaging or process re-enters review before the next production run, keeping every branch on the same specification.

Should an importer combine several beverage ingredient categories into one qualification project?

Combining categories under one project is often worthwhile for an importer aiming at mixed or repeat full-container orders, since it consolidates documentation and scheduling. Brief & Branch reviews each category’s volume separately during fit assessment, then coordinates them together once individual thresholds and specifications are confirmed.

Is a small trial order possible before committing to a full private label program?

Yes. A paid pallet or less-than-container-load (LCL) trial may be arranged for an operating business with credible recurring commercial demand. You do not need to commit to future full-container orders; ongoing LCL supply may also be considered where commercially viable.

What does the commercial fit assessment actually evaluate for an America-based buyer?

The commercial fit assessment reviews an America-based buyer’s branch count, category needs, recurring volume, packaging preference and rough timeline. Brief & Branch is Philippines-based and welcomes commercial inquiries worldwide, with supply arrangements confirmed per project. It also considers whether the buyer’s profile fits better as a direct chain account or an importer/distributor path, since Brief & Branch structures the program differently for each.

Next Step

Start with the commercial screen

Apply if the operating business meets 500 kg of powder or 500 L of syrup per flavor and intended order now, or can support a dated near-term path with current operating evidence.

Request a Commercial Fit Review